The firm owned 2,397 shares of the biopharmaceutical company’s stock after selling 4,426 shares during the period. J. Safra Sarasin Holding AG’s holdings in Madrigal Pharmaceuticals were worth $1,099,000 at the end of the most recent reporting period. Get Madrigal Pharmaceuticals alerts:Madrigal Pharmaceuticals Stock Down 0.8%Madrigal Pharmaceuticals stock opened at $496.54 on Thursday. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report). Receive News & Ratings for Madrigal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Madrigal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.